Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3017% below fair value
$318.15+0.61 (+0.19%)
Close on Nov 18, 2026Market cap $121.12BP/E 33.9Yield –
Stryker revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Stryker's revenue for the twelve months ending Sep 30, 2026 was $26.30B, up 7.9% year over year. For fiscal 2025 it was $25.12B, up 11.2% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $25.12B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.12B | +11.2% |
| FY2024 | Dec 31, 2024 | $22.60B | +10.2% |
| FY2023 | Dec 31, 2023 | $20.50B | +11.1% |
| FY2022 | Dec 31, 2022 | $18.45B | +7.8% |
| FY2021 | Dec 31, 2021 | $17.11B | +19.2% |
| FY2020 | Dec 31, 2020 | $14.35B | -3.6% |
| FY2019 | Dec 31, 2019 | $14.88B | +9.4% |
| FY2018 | Dec 31, 2018 | $13.60B | +9.3% |
| FY2017 | Dec 31, 2017 | $12.44B | +9.9% |
| FY2016 | Dec 31, 2016 | $11.33B | +13.9% |
| FY2015 | Dec 31, 2015 | $9.95B | +2.8% |
| FY2014 | Dec 31, 2014 | $9.68B | +7.2% |
| FY2013 | Dec 31, 2013 | $9.02B | +4.2% |
| FY2012 | Dec 31, 2012 | $8.66B | +4.2% |
| FY2011 | Dec 31, 2011 | $8.31B | +13.5% |
| FY2010 | Dec 31, 2010 | $7.32B | +8.9% |
| FY2009 | Dec 31, 2009 | $6.72B | +0.1% |
| FY2008 | Dec 31, 2008 | $6.72B | +12.0% |
| FY2007 | Dec 31, 2007 | $6.00B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.52B | +7.6% |
| Q2 FY2026 | Jun 30, 2026 | $6.59B | +9.4% |
| Q1 FY2026 | Mar 31, 2026 | $6.02B | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $7.17B | +11.4% |
| Q3 FY2025 | Sep 30, 2025 | $6.06B | +10.2% |
| Q2 FY2025 | Jun 30, 2025 | $6.02B | +11.1% |
| Q1 FY2025 | Mar 31, 2025 | $5.87B | +11.9% |
| Q4 FY2024 | Dec 31, 2024 | $6.44B | +10.7% |
| Q3 FY2024 | Sep 30, 2024 | $5.49B | +11.9% |
| Q2 FY2024 | Jun 30, 2024 | $5.42B | +8.5% |
| Q1 FY2024 | Mar 31, 2024 | $5.24B | +9.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.82B | +11.8% |
| Q3 FY2023 | Sep 30, 2023 | $4.91B | +9.6% |
| Q2 FY2023 | Jun 30, 2023 | $5.00B | +11.2% |
| Q1 FY2023 | Mar 31, 2023 | $4.78B | +11.8% |
| Q4 FY2022 | Dec 31, 2022 | $5.20B | +10.7% |
| Q3 FY2022 | Sep 30, 2022 | $4.48B | +7.7% |
| Q2 FY2022 | Jun 30, 2022 | $4.49B | +4.6% |
| Q1 FY2022 | Mar 31, 2022 | $4.28B | +8.1% |
| Q4 FY2021 | Dec 31, 2021 | $4.70B | +10.3% |
| Q3 FY2021 | Sep 30, 2021 | $4.16B | +11.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.29B | +55.4% |
| Q1 FY2021 | Mar 31, 2021 | $3.95B | +10.2% |
| Q4 FY2020 | Dec 31, 2020 | $4.26B | +3.2% |
| Q3 FY2020 | Sep 30, 2020 | $3.74B | +4.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.76B | -24.3% |
| Q1 FY2020 | Mar 31, 2020 | $3.59B | +2.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.13B | +8.8% |
| Q3 FY2019 | Sep 30, 2019 | $3.59B | +10.6% |
| Q2 FY2019 | Jun 30, 2019 | $3.65B | +9.9% |
| Q1 FY2019 | Mar 31, 2019 | $3.52B | +8.5% |
| Q4 FY2018 | Dec 31, 2018 | $3.80B | +9.4% |
| Q3 FY2018 | Sep 30, 2018 | $3.24B | +7.9% |
| Q2 FY2018 | Jun 30, 2018 | $3.32B | +10.3% |
| Q1 FY2018 | Mar 31, 2018 | $3.24B | +9.7% |
| Q4 FY2017 | Dec 31, 2017 | $3.47B | +9.9% |
| Q3 FY2017 | Sep 30, 2017 | $3.01B | – |
| Q2 FY2017 | Jun 30, 2017 | $3.01B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.96B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.16B | – |
See a number that looks wrong?